Methods of treating, preventing or managing triple negative breast cancer (TNBC) or clear cell renal cell carcinoma (ccRCC) are disclosed. The methods encompass the administration of an HDAC inhibitor romidepsin in combination with a cytidine analog. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods provided herein are also disclosed.
申请公布号
HK1200354(A1)
申请公布日期
2015.08.07
申请号
HK20150101006
申请日期
2015.01.29
申请人
CELGENE CORPORATION
发明人
COPLAND, III, JOHN, A. A;TUN, HAN, WIN;COOPER, SIMON, JAMES;MARLOW, LAURA, ANN